Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
| Status: | Recruiting |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | June 2006 |
| Contact: | Tara A. McCannel, M.D., Ph.D. |
| Email: | tmccannel@jsei.ucla.edu |
| Phone: | (310) 206-7487 |
Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT
scans of the whole body are performed at baseline, three months later, and six months after
that for a total of three combined scans in the first year. Subsequently, these combined
scans will be performed at 6-monthly intervals for a total of two combined scans per year.
scans of the whole body are performed at baseline, three months later, and six months after
that for a total of three combined scans in the first year. Subsequently, these combined
scans will be performed at 6-monthly intervals for a total of two combined scans per year.
Inclusion Criteria:
1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving
the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or
the part of the eye behind the iris).
2. Patients 18 years of age or older.
3. Patients able to give informed consent.
Exclusion Criteria:
1. Patients who refuse to participate in the study.
2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
3. Patients who will be moving out of the area of UCLA during the ten years of this
study.
We found this trial at
1
site
Click here to add this to my saved trials
